Member Info for gr1bbler

I must admit the error on the page 1 did make me smile:

Progress with key projects
Quadrise plans to complete the
trial at the client site in Morocco in
Q4 2020(!!!?)

I don't believe there linked rise, sadly. Actual current spread is around 3.34/3.53.

Helped myself to a 624,929 share slice of the QFI cake this morning and have seen a few more nice buys since (though of course all reported as sales)!

https://www.proactiveinvestors.co.uk/companies/news/963854/quadrise-fuels-to-monitor-morocco-flight-situation-as-preparations-for-product-trial-continue-963854.html

Old interview but may serve as a good reminder for others: https://www.proactiveinvestors.co.uk/companies/news/313796/quadrise-fuels--mike-kirk-details-agreement-to-fast-track-msar-projects-in-mexico-13796.html

I know we don't have anything concrete yet but Mexico is fast becoming one of the opportunities I am most excited about.

Where can the IMC Q&A answers be accessed please? Didn't jump out at me on the QFI website.

Thanks, Soros. Yes, I noted the comment re: MW in the call. I believe we were told the notice period was 3 months, though they may be able to announce sooner, and we don't know when the 3 months started, of course. I am fully in agreement re: the risk reward, as well as thinking it all just feels different this time. No Bergen, institutional investors on board, multiple projects on the cusp, Jason at the helm, favourable ESG narrative, fully funded, right product at the right time.

Having said that and to give a balanced view, the main risks on my radar are: agreement with refiner (we were told this should be easier with MSC tied up), Maersk issue to be resolved, Covid, glycerine supply.

As we eagerly await further updates, does anyone care to hazard a guess what the next developments are likely to be? I am under the impression we should hopefully hear about further bioMSAR testing results this month, possible further announcement on MW's replacement, possible update on MSC in advance of the AGM, Morocco trial results in November... any thoughts?

Under-promising and over-delivering? Now there would be a welcome step change!

Picked up some more recently and will be looking to invest any spare cash as I think we're in for an exciting few months.

One further notable update: Jason to smile more following delivery of commercial contract.

:)

Thanks, that's helpful Indigo. I thought the call was as good as any I've watched to date. It feels like we are close and I look forward to inching forward over the coming weeks and months!

Would someone be kind enough to summarise what the prospective issue is here? Thank you.

Mike is the Chairman, Jason is the CEO. *sigh*

Mike is the Chairman, Jason is the CEO.

His name is Philippe Cohen, though I don't know what his role is: https://www.linkedin.com/in/philippe-cohen-741a2b/

To be replaced by Laurie Mutch until new Chairman found.

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Final Results, Directorate Change, Investor Presentation and Notice of AGM

 

 

Quadrise Fuels International plc (AIM: QFI) announces its audited final results for the year ended 30 June 2021 and gives notice that the Company's Annual General Meeting ("AGM") will be held at 12 noon on 26 November 2021.

 

Highlights

 

·      Substantial progress across Quadrise's project portfolio and accelerated development of low-carbon bioMSAR™ both during and post period end despite the significant challenges posed by the COVID-19 pandemic.

 

·      Completion of significantly oversubscribed placing and open offer in March 2021 to raise net proceeds of £6.5m, ensuring that on the delivery of successful trials and entry of appropriate commercial supply agreements, the Company has the resources in place to reach sustainable commercial revenues in Q1 2023.  

 

·     bioMSAR™ - Quadrise's innovative low-carbon bioMSAR™ fuel takes advantage of our proven emulsion fuel technology platform and utilises renewable glycerine as a clean fuel component. The glycerine content of bioMSAR™ can be adjusted to meet the client's required price/CO2 reduction goals, providing a cost-effective transition fuel solution to meet increasingly stringent decarbonisation requirements. Testing of bioMSAR™ at Aquafuel Research Ltd demonstrated over 20% CO2 and NOx emissions savings, as well as higher engine efficiency results. This was followed by a larger trial using 5 tons of bioMSAR™ at the VTT facility in Finland. The VTT testing demonstrated a 26% average reduction in CO2 emissions compared to marine diesel. Plans are underway to accelerate testing for bioMSAR™ use in a range of sectors that are demanding "drop in" transition fuels to advance decarbonisation.

 

·      MSC - Following the signature of the Joint Development Agreement with MSC Shipmanagement to carry out LONO ('Letter Of No Objection') fuel trials on board their commercial container vessels, Quadrise is now working to finalise the preparatory work to enable these trials. As a result of positive results from bioMSAR™ testing on 4-stroke diesel engines, MSC expressed an interest in advancing the option of bioMSAR™ testing on their modern 2-stroke engines alongside MSAR® and this is our main focus, with a view to commencing commercial-scale 4,000-hour LONO trials in H1 2022.

 

·      Utah - Our project in Utah involves using MSAR® technology to emulsify low-sulphur heavy oil from oil-sand deposits located at the Petroteq Oil Sands Plant ('POSP') at Asphalt Ridge in Utah, USA, which is operated by Greenfield Energy LLC ("Greenfield"). Due to both COVID-19 and adverse weather conditions, the POSP start-up and commissioning process experienced delays, resulting in the required oil samples from site not being received at QRF until August 2021. During August our

Nah, probably just the Illuminati communicating to Elvis that 9/11 was a conspiracy.

Or you can set up email alerts so you are notified when an RNS is released.